Victory Capital Management Inc Beam Therapeutics Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 9,093 shares of BEAM stock, worth $229,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,093
Previous 9,921 8.35%
Holding current value
$229,961
Previous $232,000 4.31%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$22.57 - $33.14 $18,687 - $27,439
-828 Reduced 8.35%
9,093 $222,000
Q2 2024

Aug 05, 2024
BUY
$21.22 - $32.66 $20,647 - $31,778
973 Added 10.87%
9,921 $232,000
Q1 2024

May 03, 2024
SELL
$23.46 - $45.07 $7,835 - $15,053
-334 Reduced 3.6%
8,948 $295,000
Q4 2023

Feb 05, 2024
BUY
$17.69 - $30.76 $164,198 - $285,514
9,282 New
9,282 $252,000
Q2 2023

Jul 27, 2023
SELL
$29.32 - $35.99 $4,427 - $5,434
-151 Reduced 0.7%
21,483 $685,000
Q1 2023

May 02, 2023
BUY
$30.15 - $48.79 $50,561 - $81,820
1,677 Added 8.4%
21,634 $662,000
Q4 2022

Feb 10, 2023
BUY
$36.73 - $51.6 $2,093 - $2,941
57 Added 0.29%
19,957 $780,000
Q4 2022

Feb 09, 2023
SELL
$36.73 - $51.6 $47,491 - $66,718
-1,293 Reduced 6.1%
19,900 $778,000
Q3 2022

Nov 02, 2022
SELL
$39.79 - $70.31 $15,279 - $26,999
-384 Reduced 1.78%
21,193 $1.01 Million
Q2 2022

Aug 01, 2022
SELL
$29.86 - $62.36 $19.8 Million - $41.4 Million
-663,609 Reduced 96.85%
21,577 $835,000
Q1 2022

May 04, 2022
BUY
$53.73 - $82.16 $5.78 Million - $8.83 Million
107,516 Added 18.61%
685,186 $38.8 Million
Q4 2021

Feb 07, 2022
SELL
$68.02 - $99.06 $8.18 Million - $11.9 Million
-120,209 Reduced 17.22%
577,670 $46 Million
Q3 2021

Nov 02, 2021
BUY
$84.37 - $133.6 $13.8 Million - $21.9 Million
163,750 Added 30.66%
697,879 $60.7 Million
Q2 2021

Aug 03, 2021
SELL
$64.12 - $128.71 $3.81 Million - $7.66 Million
-59,476 Reduced 10.02%
534,129 $68.7 Million
Q1 2021

May 04, 2021
BUY
$71.28 - $120.75 $36.8 Million - $62.3 Million
515,886 Added 663.78%
593,605 $47.5 Million
Q4 2020

Feb 01, 2021
SELL
$22.24 - $95.63 $489,769 - $2.11 Million
-22,022 Reduced 22.08%
77,719 $6.35 Million
Q3 2020

Nov 09, 2020
SELL
$19.0 - $30.57 $350,303 - $563,619
-18,437 Reduced 15.6%
99,741 $2.46 Million
Q2 2020

Aug 07, 2020
SELL
$15.26 - $28.66 $2.24 Million - $4.2 Million
-146,693 Reduced 55.38%
118,178 $3.31 Million
Q1 2020

May 04, 2020
BUY
$13.31 - $29.2 $3.53 Million - $7.73 Million
264,871 New
264,871 $4.77 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email